Whilst there is a lack of evidence on the targets associated with this drug (AOPEP, ENPEP) in AF pathology, high circulating matrix metalloproteinase 9 was found in patients with AF as well as increased expression in atrial tissue.101. This evidence concerns the gene MMP9 and atrial fibrillation.